All news from Anaesthesiology

Revefenacin: A new drug therapy for COPD

Management of chronic obstructive pulmonary disease (COPD) is treated principally by bronchodilators and drugs that reduce the frequency and severity of acute exacerbations. We have no agents that have been shown to prolong life other than extended oxygen therapy in those COPD patients who have long-term hypoxemiaRevefenacin is a new long-acting anticholinergic agent. A study recently published in Respiratory Research demonstrates its safety and efficacy. 

Palliative Care Curbs Psychological Distress in HSCT Patients

Palliative care at the time of hematopoietic stem cell transplant (HSCT) can reduce the psychological distress caused by the transplant interventions, a new study published in the Journal of Clinical Oncology. The study found that patients who received palliative care while hospitalized for HSCT experienced a "remarkable and sustained improvement" in depression and posttraumatic stress disorder (PTSD) symptoms 6 months following their transplant.

Management of Type 1 Diabetes, a New Approach

For over a million American individuals with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell University-led research team has developed a device that could revolutionize the management of the disease.